Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Claire Long

- PMLiVE

Dr Antoine Yver moves from AstraZeneca to Daiichi Sankyo

He becomes global head, oncology research and development

- PMLiVE

Delivering digital value

Improving outcomes, the digital responsibility

- PMLiVE

Teva and Takeda appoint head of Japanese generics venture

Hiroshi Matsumori will lead partnership of Teva’s generics portfolio and Takeda brands

- PMLiVE

Pfizer’s PCSK9 inhibitor clears another phase III trial

Bococizumab will compete with Praluent and Repatha if it reaches the market

- PMLiVE

Dr Simon Chandler joins Ora as a senior director

He brings 15 years of ophthalmic industry experience

- PMLiVE

Wearables – the technologist’s view

Patient insight is key to a successful solution

LEO expands innovation lab

Adds offices in France and Canada to new digital unit

- PMLiVE

Deal Watch February 2016

Abbott, AstraZeneca and Sanofi among those featured in this month’s roundup of pharma deal activity

- PMLiVE

Diabetes: Let’s cut the Gordian knot by Debashis Bhattacharya and Kamlesh Sheth

Digital health specialists Aegleio suggest that a culture change is needed to cope with the rise of diabetes in the UK.

Say Communications

- PMLiVE

J&J drops NGF blocker fulranumab

Says decision to return rights to Amgen based on “strategic portfolio prioritisation”

- PMLiVE

GSK gene therapy tops CHMP recommendations

ADA-SCID treatment Strimvelis set for European approval

Fighting falsified drugs

Is the introduction of the Falsified Medicines Directive enough?

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links